Clinical Trial Update: Sitafloxacin-containing Regimens for Shortening Tuberculosis Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating sitafloxacin-containing regimens to shorten tuberculosis treatment in pulmonary tuberculosis; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis Pulmonary

Drugs mentioned

• sitafloxacin-containing regimens (sitafloxacin)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Tuberculosis, Pulmonary | Phase 3 | Status: NOT_YET_RECRUITING